Brian H. Dovey

Who is Brian H. Dovey?

Mr. Dovey has been a General Partner of Domain Associates since 1988.

Since joining Domain, he has served as Chairman of Athena Neurosciences,

Creative BioMolecules, and Univax Biologics and on the Board of Directors of

some 30 additional companies, including Align Technology, British Biotech,

Cardiac Science, Connetics, Geron, Ista Pharmaceuticals, Nabi

Pharmaceuticals, Neose Technologies, ReSound, Trimeris, U.S. Bioscience, and

Vivus.

Prior to Domain, Brian spent six years at Rorer Group (now

Aventis as a result of subsequent mergers). As President of Rorer from 1986

to 1988, he was the primary architect of this Fortune 500 company's

strategic shift to pharmaceuticals that resulted in a doubling of annual

sales to approximately $1 billion. Previously, Brian was President of

Survival Technology, a start-up medical products company whose sales growth

placed it in the top ten of the Inc 100. He has also held management

positions with Howmedica, Howmet Corporation, and New York Telephone.

Brian has served as both President and Chairman of the National Venture

Capital Association. He is on the Board of Trustees of the Burnham Institute

and is Vice Chair of the Wistar Institute, both of which are leaders in

preclinical bio-medical research in the non-profit sector. Mr. Brian also

serves on the Board of Directors of the Kauffman Fellows Program at the

Center for Venture Education. He is Trustee Emeritus of Germantown Academy

and a former Trustee of the University of Pennsylvania School of Nursing. He

is also a former Board Member of the Advanced Medical Technology Association

and the Consumer Healthcare Products Association.

Brian earned a Bachelor of Arts degree in Industrial Engineering from

Colgate University and a Masters of Business Administration degree from

Harvard University.